The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling
0301 basic medicine
Base Sequence
Epidermal Growth Factor
Brain Neoplasms
Molecular Sequence Data
Down-Regulation
Mice, Nude
Endocytosis
Peptide Fragments
Recombinant Proteins
Cell Line
3. Good health
ErbB Receptors
Mice
03 medical and health sciences
Mutagenesis, Site-Directed
Animals
Humans
Amino Acid Sequence
Phosphorylation
Glioblastoma
Phosphotyrosine
DNA Primers
DOI:
10.1074/jbc.272.5.2927
Publication Date:
2002-07-26T14:57:46Z
AUTHORS (10)
ABSTRACT
Deregulation of signaling by the epidermal growth factor receptor (EGFR) is common in human malignancy progression. One mutant EGFR (variously named ΔEGFR, de2-7 EGFR, or EGFRvIII), which occurs frequently cancers, lacks a portion extracellular ligand-binding domain due to genomic deletions that eliminate exons 2 7 and confers dramatic enhancement brain tumor cell tumorigenicity <i>in vivo</i>. In order dissect molecular mechanisms this activity, we analyzed location, autophosphorylation, attenuation receptors. The receptors were expressed on surface constitutively autophosphorylated at significantly decreased level compared with wild-type activated ligand treatment. Unlike active ΔEGFR not down-regulated, suggesting altered conformation did result exposure sequence motifs required for endocytosis lysosomal sorting. Mutational analysis showed enhanced was dependent intrinsic tyrosine kinase activity mediated through carboxyl terminus. contrast receptor, mutation any major autophosphorylation site abolished these activities biological functions are low constitutive activation mitogenic effects amplified failure attenuate down-regulation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (72)
CITATIONS (457)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....